1. Home
  2. CUE vs CPBI Comparison

CUE vs CPBI Comparison

Compare CUE & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • CPBI
  • Stock Information
  • Founded
  • CUE 2014
  • CPBI 2023
  • Country
  • CUE United States
  • CPBI United States
  • Employees
  • CUE N/A
  • CPBI N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • CPBI
  • Sector
  • CUE Health Care
  • CPBI
  • Exchange
  • CUE Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • CUE 58.9M
  • CPBI 57.1M
  • IPO Year
  • CUE 2018
  • CPBI N/A
  • Fundamental
  • Price
  • CUE $0.78
  • CPBI $14.83
  • Analyst Decision
  • CUE Strong Buy
  • CPBI
  • Analyst Count
  • CUE 3
  • CPBI 0
  • Target Price
  • CUE $3.00
  • CPBI N/A
  • AVG Volume (30 Days)
  • CUE 158.3K
  • CPBI 6.1K
  • Earning Date
  • CUE 05-20-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • CUE N/A
  • CPBI N/A
  • EPS Growth
  • CUE N/A
  • CPBI 29.70
  • EPS
  • CUE N/A
  • CPBI 1.62
  • Revenue
  • CUE $9,287,000.00
  • CPBI $18,546,000.00
  • Revenue This Year
  • CUE N/A
  • CPBI N/A
  • Revenue Next Year
  • CUE $25.99
  • CPBI N/A
  • P/E Ratio
  • CUE N/A
  • CPBI $9.18
  • Revenue Growth
  • CUE 69.16
  • CPBI 13.73
  • 52 Week Low
  • CUE $0.45
  • CPBI $9.96
  • 52 Week High
  • CUE $2.26
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • CUE 46.03
  • CPBI 52.99
  • Support Level
  • CUE $0.71
  • CPBI $14.70
  • Resistance Level
  • CUE $0.78
  • CPBI $14.77
  • Average True Range (ATR)
  • CUE 0.06
  • CPBI 0.06
  • MACD
  • CUE 0.01
  • CPBI 0.02
  • Stochastic Oscillator
  • CUE 46.11
  • CPBI 67.39

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

Share on Social Networks: